Russell Investments Group
VINC

Russell Investments Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Russell Investments Group’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,311
Closed -$284K – 2978
2022
Q3 		$284K Buy
+10,311
New +$297K ﹤0.01% 2453
2022
Q2 		– Sell
-11,347
Closed -$906K – 2983
2022
Q1 		$906K Buy
11,347
+8,174
+258% +$1.01M ﹤0.01% 2009
2021
Q4 		$644K Buy
3,173
+347
+12% +$86.6K ﹤0.01% 2348
2021
Q3 		$912K Sell
2,826
-161
-5% -$47K ﹤0.01% 2229
2021
Q2 		$775K Buy
+2,987
New +$910K ﹤0.01% 2426

Other funds holding VINC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Russell Investments Group's VINC Position: Q4 2022 in Review

Russell Investments Group sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q4 2022, closing a stake of 10,311 shares — an estimated $284K sold.

Russell Investments Group first reported a position in VINC in Q2 2021 and held it in 5 quarters. The position peaked at $912K in Q3 2021. 35 funds tracked by Wall St. Rank hold VINC as of Q4 2022.

  • Russell Investments Group reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 10,311 Vincerx Pharma, Inc. Common Stock shares in Q4 2022, an estimated $284K.
  • Russell Investments Group first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Russell Investments Group's Vincerx Pharma, Inc. Common Stock position peaked at $912K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.